Changes in Antihypertensive Medication Following Bariatric Surgery

التفاصيل البيبلوغرافية
العنوان: Changes in Antihypertensive Medication Following Bariatric Surgery
المؤلفون: Gabriel S. Tajeu, Emily Johnson, Mason Buccilla, Crystal A. Gadegbeku, Shane Janick, Daniel Rubin, Rohit Soans, Vikram J. Eddy, David B. Sarwer
المصدر: Obes Surg
بيانات النشر: Springer Science and Business Media LLC, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Adult, Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism, Gastric Bypass, Bariatric Surgery, Article, Obesity, Morbid, Treatment Outcome, Gastrectomy, Hypertension, Humans, Laparoscopy, Surgery, Antihypertensive Agents
الوصف: Obesity is a leading cause of hypertension (i.e., high blood pressure [BP]). While hypertension can be managed with antihypertensive medication, substantial weight loss can also lower BP, reducing the need for antihypertensive medication. Articles in this review (n = 60) presented data on antihypertensive medication use among adults pre- and postoperatively. Roux-en-Y gastric bypass was the most studied surgical approach followed by Laparoscopic Sleeve Gastrectomy. Antihypertensive medication was discontinued in a large proportion of patients after surgery, and the mean number of antihypertensive medications decreased by approximately one. In almost a third of the studies, over 75% of participants experienced hypertension remission. All articles aside from two reported a decrease in systolic BP, with about 40% reporting a decrease of ≥ 10 mm Hg.
تدمد: 1708-0428
0960-8923
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c418fa9f99254b42ecb73b257c73acd9Test
https://doi.org/10.1007/s11695-022-05893-5Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....c418fa9f99254b42ecb73b257c73acd9
قاعدة البيانات: OpenAIRE